204541 people have viewed this drug in the last 60 days
Updated 2025-10-03
| Last Update | 2023-04-05 |
| Register Year | 2017 |
| Product Type | Human |
| Drug Type | NCE |
| Scientific Name | VANDETANIB |
| Trade Name | CAPRELSA 300 mg film-coated tablet |
| Strength Unit | mg |
| Pharmaceutical Form | Film-coated tablet |
| Administration Route | Oral use |
| Atc Code1 | L01XE12 |
| Atc Code2 | |
| Size | 0 |
| Size Unit | |
| Package Types | Blister |
| Package Size | 30 |
| Legal Status | Prescription |
| Product Control | Uncontrolled |
| Distribute Area | Pharmacy |
| Public price | $20056.2 |
| Shelf Life | 48 Months |
| Marketing Company | GENZYME EUROPE B.V. |
| Marketing Country | Netherlands |
| Manufacture Name | IPR PHARMACEUTICALS INC. |
| Manufacture Country | Puerto Rico |
| Secondry package manufacture | |
| Main Agent | Sanofi Arabia Trading Co. Ltd |
| Secosnd Agent | |
| Third Agent | |
| Visits | 204541 |
Do not forget, after purchasing the medicine, help us determine the price more accurately, press the button below and adjust the price directly
| Name | Price | Visits | Updated |
|---|---|---|---|
| CAPRELSA 300 mg film-coated tablet | $20056.2 | 204541 visits | 2023-04-05 |
| CAPRELSA 100 mg film-coated tablet | $7517.65 | 260500 visits | 2023-04-05 |